Biogen's Trading Volume Surges 88.13% to $240 Million, Ranked 445th in Daily Volume

On April 23, 2025, Biogen's trading volume reached $240 million, marking an 88.13% increase from the previous day. This surge placed Biogen at the 445th position in terms of trading volume for the day. However, the stock price of Biogen (BIIB) decreased by 0.61%.

Biogen's stock has been subject to various analyst evaluations over the past three months, with a mix of bullish and bearish perspectives. The company has an average rating of overweight, with a mean price target of $190.44, according to analysts polled by FactSet. This indicates a potential upside for investors considering Biogen's stock.

Goldman Sachs recently adjusted its price target for Biogen, setting it at $197. This adjustment reflects the firm's confidence in the company's future performance and potential for growth. The current share price of Biogen is $118.89, with a 52-week high of $238.00 and a 52-week low of $110.04. These figures provide a range within which Biogen's stock has traded over the past year, offering insights into its volatility and potential for price movements.